These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Growth hormone releasing hormone plus arginine stimulation testing in young adults treated in childhood with cranio-spinal radiation therapy. Ham JN; Ginsberg JP; Hendell CD; Moshang T Clin Endocrinol (Oxf); 2005 May; 62(5):628-32. PubMed ID: 15853837 [TBL] [Abstract][Full Text] [Related]
4. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831 [TBL] [Abstract][Full Text] [Related]
5. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. Mulhern RK; Palmer SL; Reddick WE; Glass JO; Kun LE; Taylor J; Langston J; Gajjar A J Clin Oncol; 2001 Jan; 19(2):472-9. PubMed ID: 11208841 [TBL] [Abstract][Full Text] [Related]
6. Determinants of altered sleep-wake rhythmicity in patients treated for nonfunctioning pituitary macroadenomas. Joustra SD; Kruijssen E; Verstegen MJ; Pereira AM; Biermasz NR J Clin Endocrinol Metab; 2014 Dec; 99(12):4497-505. PubMed ID: 25210880 [TBL] [Abstract][Full Text] [Related]
7. Long-term results of a pilot study of low dose cranial-spinal irradiation for cerebellar medulloblastoma. Brand WN; Schneider PA; Tokars RP Int J Radiat Oncol Biol Phys; 1987 Nov; 13(11):1641-5. PubMed ID: 3667370 [TBL] [Abstract][Full Text] [Related]
8. A prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth. Brauner R; Rappaport R; Prevot C; Czernichow P; Zucker JM; Bataini P; Lemerle J; Sarrazin D; Guyda HJ J Clin Endocrinol Metab; 1989 Feb; 68(2):346-51. PubMed ID: 2645307 [TBL] [Abstract][Full Text] [Related]
9. [Neuroendocrine changes induced by craniospinal radiation in children with acute lymphoblastic leukemia and medulloblastoma]. Couce Pico ML; Couselo Sánchez JM; Pombo Arias M; Devesa Múgica J An Esp Pediatr; 1989 Feb; 30(2):85-90. PubMed ID: 2719421 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood. Link K; Moëll C; Garwicz S; Cavallin-Ståhl E; Björk J; Thilén U; Ahrén B; Erfurth EM J Clin Endocrinol Metab; 2004 Oct; 89(10):5003-12. PubMed ID: 15472198 [TBL] [Abstract][Full Text] [Related]
12. Diffusion tensor magnetic resonance imaging finding of discrepant fractional anisotropy between the frontal and parietal lobes after whole-brain irradiation in childhood medulloblastoma survivors: reflection of regional white matter radiosensitivity? Qiu D; Kwong DL; Chan GC; Leung LH; Khong PL Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):846-51. PubMed ID: 17544593 [TBL] [Abstract][Full Text] [Related]
13. Long-term neuromotor speech deficits in survivors of childhood posterior fossa tumors: effects of tumor type, radiation, age at diagnosis, and survival years. Huber JF; Bradley K; Spiegler B; Dennis M J Child Neurol; 2007 Jul; 22(7):848-54. PubMed ID: 17715277 [TBL] [Abstract][Full Text] [Related]
14. The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals. Achermann JC; Hindmarsh PC; Robinson IC; Matthews DR; Brook CG Clin Endocrinol (Oxf); 1999 Nov; 51(5):575-85. PubMed ID: 10594518 [TBL] [Abstract][Full Text] [Related]
15. Vulnerability of white matter to insult during childhood: evidence from patients treated for medulloblastoma. Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Sharpe MB; Laughlin S; Bartels U; Scantlebury N; Law N; Malkin D; Skocic J; Richard L; Mabbott DJ J Neurosurg Pediatr; 2016 Jul; 18(1):29-40. PubMed ID: 27015518 [TBL] [Abstract][Full Text] [Related]
16. Language skills following risk-adapted treatment for medulloblastoma. Lewis F; Murdoch B Dev Neurorehabil; 2010; 13(3):217-24. PubMed ID: 20450472 [TBL] [Abstract][Full Text] [Related]
17. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. Mulhern RK; Kepner JL; Thomas PR; Armstrong FD; Friedman HS; Kun LE J Clin Oncol; 1998 May; 16(5):1723-8. PubMed ID: 9586884 [TBL] [Abstract][Full Text] [Related]
18. [Growth hormone deficiency after treatment of medulloblastoma with radiotherapy in childhood: case report]. Goldberg TB; Rodrigues MA; Takata RT; Nogueira CR; Faleiros AT Arq Neuropsiquiatr; 2003 Jun; 61(2B):482-5. PubMed ID: 12894290 [TBL] [Abstract][Full Text] [Related]
19. Preliminary results of conformal radiation therapy for medulloblastoma. Merchant TE; Happersett L; Finlay JL; Leibel SA Neuro Oncol; 1999 Jul; 1(3):177-87. PubMed ID: 11550312 [TBL] [Abstract][Full Text] [Related]
20. Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. Oyharcabal-Bourden V; Kalifa C; Gentet JC; Frappaz D; Edan C; Chastagner P; Sariban E; Pagnier A; Babin A; Pichon F; Neuenschwander S; Vinchon M; Bours D; Mosseri V; Le Gales C; Ruchoux M; Carrie C; Doz F J Clin Oncol; 2005 Jul; 23(21):4726-34. PubMed ID: 16034048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]